Basket | Login | Register


ACI-35.030 (coming soon)

Phase II trials

Study Information

Name of the study

A study to evaluate the safety, tolerability and immunogenicity of Tau targeted vaccines in participants with early Alzheimer's disease

Study sponsor

AC Immune SA


Early Alzheimer's disease


Phase Ib/IIa

Information about the drug that will be tested in the studies

Name of the drug


Where and when will the study be conducted?

European countries involved in the trial (active)

  • Finland
  • The Netherlands

European country that will be involved in the trial (planned)

  • UK

Information for your doctor identifier


Link to full text



Last Updated: Wednesday 11 November 2020